- Home
- FOLD vs QUBT Comparison
FOLD vs QUBT Comparison
Compare FOLD & QUBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- QUBT
- Stock Information
- Founded
- FOLD 2002
- QUBT 2001
- Country
- FOLD United States
- QUBT United States
- Employees
- FOLD N/A
- QUBT N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- QUBT Computer Manufacturing
- Sector
- FOLD Health Care
- QUBT Technology
- Exchange
- FOLD Nasdaq
- QUBT Nasdaq
- Market Cap
- FOLD 2.9B
- QUBT 2.7B
- IPO Year
- FOLD 2007
- QUBT N/A
- Fundamental
- Price
- FOLD $7.58
- QUBT $15.78
- Analyst Decision
- FOLD Strong Buy
- QUBT Buy
- Analyst Count
- FOLD 10
- QUBT 2
- Target Price
- FOLD $26.89
- QUBT $18.50
- AVG Volume (30 Days)
- FOLD 3.8M
- QUBT 15.9M
- Earning Date
- FOLD 07-31-2025
- QUBT 08-14-2025
- Dividend Yield
- FOLD N/A
- QUBT N/A
- EPS Growth
- FOLD N/A
- QUBT N/A
- EPS
- FOLD N/A
- QUBT N/A
- Revenue
- FOLD $571,160,000.00
- QUBT $263,000.00
- Revenue This Year
- FOLD $20.98
- QUBT $64.08
- Revenue Next Year
- FOLD $20.74
- QUBT $383.33
- P/E Ratio
- FOLD N/A
- QUBT N/A
- Revenue Growth
- FOLD 25.35
- QUBT N/A
- 52 Week Low
- FOLD $5.51
- QUBT $0.58
- 52 Week High
- FOLD $12.65
- QUBT $27.15
- Technical
- Relative Strength Index (RSI)
- FOLD 69.88
- QUBT 49.64
- Support Level
- FOLD $7.40
- QUBT $14.70
- Resistance Level
- FOLD $7.80
- QUBT $16.09
- Average True Range (ATR)
- FOLD 0.22
- QUBT 0.98
- MACD
- FOLD 0.01
- QUBT 0.09
- Stochastic Oscillator
- FOLD 87.61
- QUBT 64.97
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.